Icosavax Raises $100m To Take RSV, COVID-19 Vaccines Into The Clinic

Platform Enables Vaccines Based On Non-Naturally Occurring VLPs

 
• By Mandy Jackson
  
Vaccine vial dose
Icosavax's first vaccines aim to prevent COVID-19 and pneumonia • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Financing

More from Business